comparison of two doses of dexmedetomidine for emergence and recovery in lap surgeries

Assessing the effect of two doses of Dexmedetomidine infusion 0.3mcgs/kg and 0.5mcgs/kg on Emergence Agitation and Quality of recovery after Laparoscopic Surgeries - dexmedetomidine

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110820

Enrollment

Registered

2026-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: dexmedetomidine: dexmedetomidine infusion of 0.3mcgs/kg and 0.5mcgs/kg for 1 min iv Control Intervention1: dexmedetomidine: 0.3mcgs/kg and 0.5mcgs/kg iv

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 and 2 Age between 18 to 60 yrs Elective laparoscopic surgeries under general anaesthesia Patients giving valid informed consent

Exclusion criteria

Exclusion criteria: Patient refusal Age less than 18 and more than 60 ASA grade 3 and 4 Patients with neuromuscular disorders

Design outcomes

Primary

Measure	Time frame
to compare the effect of Emergence Agitation and Quality of recovery in Laparoscopic Surgeries using dexmedTimepoint: from 0 min till extubation	—

Secondary

Measure	Time frame
to compare the hemodynamic parameters of dexmedetomidine between the two groupsTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Sudharsan M V D

Vinayaka Missions Kirupananda Varrier Medical College and Hospitals

rasikamadhan1985@gmail.com8129340367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026